BRPI0822454A2 - Processo para preparação de sulfamatos de heteroarila benzo-fundidos e forma cristalina de n-(((2s)-6-cloro-2,3-diidro-1,4-benzodioxin-2yl)metil-su lfamida - Google Patents

Processo para preparação de sulfamatos de heteroarila benzo-fundidos e forma cristalina de n-(((2s)-6-cloro-2,3-diidro-1,4-benzodioxin-2yl)metil-su lfamida

Info

Publication number: BRPI0822454A2
Authority: BR; Brazil
Prior art keywords: methylsulphamide; sulfamates; benzodioxin; benzo; dihydro
Prior art date: 2008-03-26

Application number

BRPI0822454-4A

Other languages

English (en)

Inventor

Ahmed F Abdel-Magid

Steven J Mehrman

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-26

Filing date

2008-03-26

Publication date

2015-06-16

2008-03-26 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2015-06-16 Publication of BRPI0822454A2 publication Critical patent/BRPI0822454A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/04—Seven-membered rings not condensed with other rings
- C07D321/08—1,4-Dioxepines; Hydrogenated 1,4-dioxepines

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

BRPI0822454-4A 2008-03-26 2008-03-26 Processo para preparação de sulfamatos de heteroarila benzo-fundidos e forma cristalina de n-(((2s)-6-cloro-2,3-diidro-1,4-benzodioxin-2yl)metil-su lfamida BRPI0822454A2 (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2008/058233 WO2009120191A1 (en)	2008-03-26	2008-03-26	Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide

Publications (1)

Publication Number	Publication Date
BRPI0822454A2 true BRPI0822454A2 (pt)	2015-06-16

Family

ID=40030223

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0822454-4A BRPI0822454A2 (pt)	2008-03-26	2008-03-26	Processo para preparação de sulfamatos de heteroarila benzo-fundidos e forma cristalina de n-(((2s)-6-cloro-2,3-diidro-1,4-benzodioxin-2yl)metil-su lfamida

Country Status (14)

Country	Link
EP (1)	EP2280950A1 (pt)
JP (1)	JP2011515464A (pt)
KR (1)	KR20100126535A (pt)
CN (1)	CN101981019A (pt)
AU (1)	AU2008353491A1 (pt)
BR (1)	BRPI0822454A2 (pt)
CA (1)	CA2719624A1 (pt)
CR (1)	CR11761A (pt)
EA (1)	EA201071120A1 (pt)
EC (1)	ECSP10010499A (pt)
IL (1)	IL208222A0 (pt)
MX (1)	MX2010010595A (pt)
WO (1)	WO2009120191A1 (pt)
ZA (1)	ZA201007611B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY147767A (en)	2004-06-16	2013-01-31	Janssen Pharmaceutica Nv	Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EP1881959A1 (en)	2005-05-20	2008-01-30	Janssen Pharmaceutica N.V.	Process for preparation of sulfamide derivatives
US8691867B2 (en)	2005-12-19	2014-04-08	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en)	2005-12-19	2015-01-20	Janssen Pharmaceutica Nv	Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en)	2005-12-19	2013-07-30	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
AU2007253814A1 (en)	2006-05-19	2007-11-29	Janssen Pharmaceutica N.V.	Co-therapy for the treatment of epilepsy
WO2010008776A2 (en) *	2008-06-23	2010-01-21	Janssen Pharmaceutica Nv	Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems
US8815939B2 (en)	2008-07-22	2014-08-26	Janssen Pharmaceutica Nv	Substituted sulfamide derivatives
CN107954906B (zh) *	2017-11-24	2020-10-16	西北师范大学	一种芳基磺酰叔胺类化合物的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4513006A (en) *	1983-09-26	1985-04-23	Mcneil Lab., Inc.	Anticonvulsant sulfamate derivatives
MY147767A (en) *	2004-06-16	2013-01-31	Janssen Pharmaceutica Nv	Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AR049646A1 (es) *	2004-06-16	2006-08-23	Janssen Pharmaceutica Nv	Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
CA2578407A1 (en) *	2004-08-24	2006-03-02	Janssen Pharmaceutica N.V.	Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
TW200738669A (en) *	2006-02-22	2007-10-16	Janssen Pharmaceutica Nv	Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide

2008
- 2008-03-26 EA EA201071120A patent/EA201071120A1/ru unknown
- 2008-03-26 JP JP2011501761A patent/JP2011515464A/ja not_active Withdrawn
- 2008-03-26 CN CN2008801285434A patent/CN101981019A/zh active Pending
- 2008-03-26 KR KR1020107023447A patent/KR20100126535A/ko not_active Withdrawn
- 2008-03-26 EP EP08744381A patent/EP2280950A1/en not_active Withdrawn
- 2008-03-26 BR BRPI0822454-4A patent/BRPI0822454A2/pt not_active IP Right Cessation
- 2008-03-26 AU AU2008353491A patent/AU2008353491A1/en not_active Abandoned
- 2008-03-26 MX MX2010010595A patent/MX2010010595A/es unknown
- 2008-03-26 CA CA2719624A patent/CA2719624A1/en not_active Abandoned
- 2008-03-26 WO PCT/US2008/058233 patent/WO2009120191A1/en not_active Ceased
2010
- 2010-09-19 IL IL208222A patent/IL208222A0/en unknown
- 2010-09-24 EC EC2010010499A patent/ECSP10010499A/es unknown
- 2010-10-25 ZA ZA2010/07611A patent/ZA201007611B/en unknown
- 2010-10-26 CR CR11761A patent/CR11761A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN101981019A (zh)	2011-02-23
AU2008353491A1 (en)	2009-10-01
MX2010010595A (es)	2010-10-25
IL208222A0 (en)	2010-12-30
KR20100126535A (ko)	2010-12-01
ECSP10010499A (es)	2010-10-30
ZA201007611B (en)	2012-04-25
CR11761A (es)	2011-07-06
EA201071120A1 (ru)	2011-06-30
CA2719624A1 (en)	2009-10-01
WO2009120191A1 (en)	2009-10-01
EP2280950A1 (en)	2011-02-09
JP2011515464A (ja)	2011-05-19

Similar Documents

Publication	Publication Date	Title
BRPI0822454A2 (pt)	2015-06-16	Processo para preparação de sulfamatos de heteroarila benzo-fundidos e forma cristalina de n-(((2s)-6-cloro-2,3-diidro-1,4-benzodioxin-2yl)metil-su lfamida
PT1896065E (pt)	2011-08-31	Processo para a preparação de vacinas
BRPI1009481A2 (pt)	2016-03-01	compostos de 2-acetamido-5-aril-1,2,4-triazolonas substituídas, seu processo de preparação, seu uso e medicamento compreendendo os mesmos
BRPI0720068A2 (pt)	2013-12-24	Processo para preparar nanocápsulas, produto, nanocápsulas e composição
BRPI0807319A2 (pt)	2017-05-02	base de minociclina, base de miniciclina cristalizada, processo para preparar base de minociclina cristalina e processo para preparar base de minociclina amorfa.
BRPI0818533A2 (pt)	2017-06-06	composto, composição farmacêutica, e, processo para a preparação de um composto
EP1978137A4 (en)	2010-04-07	METHOD FOR THE PRODUCTION OF SIC-EINKRISTALL
BRPI0814163A2 (pt)	2015-01-20	Processo para a preparação de compostos, forma cristalina, e, composição farmacêutica
BRPI0820851A2 (pt)	2015-06-16	Processo para preparar microcápsulas
BRPI0821801A2 (pt)	2015-07-14	Zeólito e processo de preparação de um zeólito.
BRPI0810850A2 (pt)	2014-10-29	Processo para carbonilação de dimetil éter
BRPI0815784A2 (pt)	2015-02-24	Processo para a preparação de 1,2-propanodiol
BRPI1014691A2 (pt)	2015-08-25	Composto, e, processo para a preparação de um composto.
BRPI1008987A2 (pt)	2016-03-22	processo para preparar 3,3,3-trifluoropropeno
BRPI0815971A2 (pt)	2015-02-18	Processo para a preparação de 1,2-propanodiol
BRPI0814448A2 (pt)	2016-07-26	processo de produção de trazodona e cloridrato de trazodona, trazodona e cloridrato de trazodona, e, composição farmacêutica
BRPI0813788A2 (pt)	2014-12-30	Processo para preparação de metacrilato de alila
BRPI0821471A2 (pt)	2014-12-23	Processo para a preparação de isomalto-oligossacarídeo hidrogenado, e, xarope de isomalto-oligossacarídeo hidrogenado
BRPI1010546A2 (pt)	2015-08-25	Processo para produzir composto, método para isolar e purificar cristais de solvato do composto, e , uso do composto.
BRPI0911992A2 (pt)	2015-10-20	processo para preparação de bifenilanilidas substituídas
BRPI0914792A2 (pt)	2015-10-20	processo para a preparação de polióis
BR112012003775A2 (pt)	2016-04-12	processo para a preparação de um composto, composto e composição
BRPI1011351A2 (pt)	2016-03-08	solução, uso de uma solução, terpolímero, processo para preparar terpolímeros,e uso de terpolímeros
CR10685A (es)	2009-05-22	Proceso para estabilizaciuon de famotidina
BRPI0821234A2 (pt)	2015-06-16	Processo de preparação de pirocatecol purificado, e pirocatecol.

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.